Back নীলিমা অরুণ ক্ষীরসাগর Bengali/Bangla નીલિમા અરુણ ક્ષીરસાગર Gujarati नीलिमा अरुण क्षीरसागर Hindi Nilima Arun Kshirsagar Italian ನಿಲಿಮಾ ಅರುಣ್ ಕ್ಷೀರ್ಸಾಗರ್ Kannada നീലിമ അരുൺ ക്ഷീരസാഗർ Malayalam नीलिमा अरुण क्षीरसागर Marathi ਨੀਲਮਾ ਅਰੁਣ ਕਸ਼ੀਰਸਾਗਰ Punjabi నీలిమా అరుణ్ క్షీరసాగర్ Tegulu
Nilima Arun Kshirsagar | |
|---|---|
| Born | 1949 (age 75–76) |
| Education | Doctor of Medicine King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College |
| Medical career | |
| Profession | Clinical Pharmacologists |
| Research | Liposomal Formulations |
Nilima Arun Kshirsagar (born 1949) is an Indian clinical pharmacologist who developed and patented liposomal amphotericin B and its drug delivery system in 1993.[1] She is the former dean of King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College.[2] She is the national chairperson in clinical pharmacology at Indian Council of Medical Research (ICMR) and president of the South Asian chapter of the American college of clinical pharmacology. She is a Member of the WHO Committees on Product development and Drug statistics Methodology.
Kshirsagar is a fellow of the National Academy of Sciences, India, a fellow of the Searle Research Center, England, Faculty of Pharmaceutical Medicine UK and Fellow of American College of Clinical Pharmacology, USA. She is the Chair of the core training Panel of Pharmacovigilance Programme of India.[3][4][5]
She established departments of Clinical Pharmacology at KEM Hospital and at Nair Hospital Mumbai. The drug Liposomal Amphotericin-b, used to treat the Indian Mucormycosis epidemic of 2021 was developed and patented in India by Nalini Kshirsagar in 1993.[1]
- ^ a b SK Pandya, BG Kirodian, S Sanath, NA Kshirsagar (2005). "Liposomal drug delivery system from laboratory to clinic". Journal of Postgraduate Medicine. 51 (5): S5-15. PMID 16519249. Retrieved 30 May 2021.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Cite error: The named reference
KEM Hospital gets private touchwas invoked but never defined (see the help page). - ^ "South Asian chapter of American college of clinical Pharmacology". Retrieved 28 May 2021.
- ^ ""Drugs for Neglected Diseases initiative (DNDi)."". Drugs for Neglected Diseases initiative (DNDi). Retrieved 28 May 2021.
- ^ "SC refers 349 FDC medicines to Drug Advisory Board for relook". Economic Times. 15 December 2017. Retrieved 30 May 2021.